Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators

Francesca Brun; Judith A. Groeneweg; Kathleen Gear; Gianfranco Sinagra; Jeroen van der Heijden; Luisa Mestroni; Richard N. Hauer; Mark Borgstrom; Trina Hughes; Frank I. Marcus

doi:10.1016/j.jacep.2016.03.015

Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators

Francesca Brun, Judith A. Groeneweg, Kathleen Gear, Gianfranco Sinagra, Jeroen van der Heijden, Luisa Mestroni, Richard N. Hauer, Mark Borgstrom, Trina Hughes, Frank I. Marcus^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

Abstract

Objectives The primary objective of this study is risk stratification of patients with arrhythmic right ventricular cardiomyopathy (ARVC). Background There is a need to identify those who need an automatic implantable cardioverter-defibrillator (ICD) to prevent sudden death. Methods This is an analysis of 88 patients with ARVC from 3 centers and who were not treated with an ICD. Results Risk factors for subsequent arrhythmic deaths were pre-enrollment sustained or nonsustained ventricular tachycardia and decreased left ventricular function. Conclusions These factors serve as proposed guidelines for implantation of an ICD in patients with ARVC to prevent sudden death.

Original language	English
Pages (from-to)	558-564
Number of pages	7
Journal	JACC: Clinical Electrophysiology
Volume	2
Issue number	5
DOIs	https://doi.org/10.1016/j.jacep.2016.03.015
Publication status	Published - 1 Oct 2016

Keywords

arrhythmogenesis
arrhythmogenic right ventricular cardiomyopathy
risk stratification in ARVC

Access to Document

10.1016/j.jacep.2016.03.015

Cite this

@article{0162c4d9af0c4b95843d8c3f64cf4a24,

title = "Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators",

abstract = "Objectives The primary objective of this study is risk stratification of patients with arrhythmic right ventricular cardiomyopathy (ARVC). Background There is a need to identify those who need an automatic implantable cardioverter-defibrillator (ICD) to prevent sudden death. Methods This is an analysis of 88 patients with ARVC from 3 centers and who were not treated with an ICD. Results Risk factors for subsequent arrhythmic deaths were pre-enrollment sustained or nonsustained ventricular tachycardia and decreased left ventricular function. Conclusions These factors serve as proposed guidelines for implantation of an ICD in patients with ARVC to prevent sudden death.",

keywords = "arrhythmogenesis, arrhythmogenic right ventricular cardiomyopathy, risk stratification in ARVC",

author = "Francesca Brun and Groeneweg, {Judith A.} and Kathleen Gear and Gianfranco Sinagra and {van der Heijden}, Jeroen and Luisa Mestroni and Hauer, {Richard N.} and Mark Borgstrom and Trina Hughes and Marcus, {Frank I.}",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.jacep.2016.03.015",

language = "English",

volume = "2",

pages = "558--564",

number = "5",

}

TY - JOUR

T1 - Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators

AU - Brun, Francesca

AU - Groeneweg, Judith A.

AU - Gear, Kathleen

AU - Sinagra, Gianfranco

AU - van der Heijden, Jeroen

AU - Mestroni, Luisa

AU - Hauer, Richard N.

AU - Borgstrom, Mark

AU - Hughes, Trina

AU - Marcus, Frank I.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Objectives The primary objective of this study is risk stratification of patients with arrhythmic right ventricular cardiomyopathy (ARVC). Background There is a need to identify those who need an automatic implantable cardioverter-defibrillator (ICD) to prevent sudden death. Methods This is an analysis of 88 patients with ARVC from 3 centers and who were not treated with an ICD. Results Risk factors for subsequent arrhythmic deaths were pre-enrollment sustained or nonsustained ventricular tachycardia and decreased left ventricular function. Conclusions These factors serve as proposed guidelines for implantation of an ICD in patients with ARVC to prevent sudden death.

AB - Objectives The primary objective of this study is risk stratification of patients with arrhythmic right ventricular cardiomyopathy (ARVC). Background There is a need to identify those who need an automatic implantable cardioverter-defibrillator (ICD) to prevent sudden death. Methods This is an analysis of 88 patients with ARVC from 3 centers and who were not treated with an ICD. Results Risk factors for subsequent arrhythmic deaths were pre-enrollment sustained or nonsustained ventricular tachycardia and decreased left ventricular function. Conclusions These factors serve as proposed guidelines for implantation of an ICD in patients with ARVC to prevent sudden death.

KW - arrhythmogenesis

KW - arrhythmogenic right ventricular cardiomyopathy

KW - risk stratification in ARVC

UR - http://www.scopus.com/inward/record.url?scp=84993983125&partnerID=8YFLogxK

U2 - 10.1016/j.jacep.2016.03.015

DO - 10.1016/j.jacep.2016.03.015

M3 - Article

AN - SCOPUS:84993983125

SN - 2405-500X

VL - 2

SP - 558

EP - 564

JO - JACC: Clinical Electrophysiology

JF - JACC: Clinical Electrophysiology

IS - 5

ER -

Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this